Fred Cohen, MD

“As someone who has battled with migraine all my life, I'm passionate about providing care and resources to help others.”

Headache Doctor lecturing

VIDEOS

CBS News - Doctors say climate change can cause migraines and headaches

NeurologyLive - Combined Use of CGRP Medications and OnabotulinumtoxinA in Migraine

HeadWise - Ketamine and Migraine

Headache Journal - The role of artificial intelligence in headache medicine: Potential and peril

Migraine World Summit - Is Migraine a Progressive Disease?

Pharmacy Times - Fred Cohen Interview

NEWS ARTICLES

Audio

ARTICLES

Headache and Digital Health: The Future of Headache Medicine

Prevalence and burden of migraine in the United States: A systematic review

Artificial intelligence and social media: (Appropriately) harnessing headache medicine's new arsenal in the 21st century

Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center

Unraveling the MSG-Headache Controversy: an Updated Literature Review

The Role of Artificial Intelligence in Headache Medicine: Potential and Peril

From diet to disasters, lifestyle factors can affect headaches and migraine

Caution regarding fabricated citations from artificial intelligence

Burden of Migraine and Migraine-Associated Symptoms in People with Differing Ethnic and Racial Backgrounds: Results of the OVERCOME (US) Study

Ketamine for Intractable Headache

CGRP-targeted Monoclonal Antibodies and Antagonists in Migraine; Current Evidence and Rationale

Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations

The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine

Headache associated with cervical spine dysfunction

A randomized study of IV prochlorperazine plus diphenhydramine versus IV hydromorphone for migraine-associated symptoms: A post hoc analysis

Efficacy and Tolerability of Calcitonin Gene-Related Peptide Targeted Monoclonal Antibody Medications as Add-on Therapy to OnabotulinumtoxinA in Patients with Chronic Migraine

Indeterminate Serotonin Release Assays Are Associated with a High Mortality Rate